
|Articles|October 15, 2018
Personalized Treatments Hold Promise for Lymphoma Patients
Author(s)Stephanie Stephens, MA
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
Advertisement
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
Intervention boosts connected insulin pen adoption among minorities with Type 1 diabetes
3
Loss of copay assistance linked to worse outcomes in retina patients | ASRS 2026
4
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
5


























